5,625 reports of this reaction
3.7% of all DOCETAXEL reports
#5 most reported adverse reaction
HAIR DISORDER is the #5 most commonly reported adverse reaction for DOCETAXEL, manufactured by Avyxa Pharma, LLC. There are 5,625 FDA adverse event reports linking DOCETAXEL to HAIR DISORDER. This represents approximately 3.7% of all 152,097 adverse event reports for this drug.
Patients taking DOCETAXEL who experience hair disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAIR DISORDER is moderately reported among DOCETAXEL users, representing a notable but not dominant share of adverse events.
In addition to hair disorder, the following adverse reactions have been reported for DOCETAXEL:
The following drugs have also been linked to hair disorder in FDA adverse event reports:
HAIR DISORDER has been reported as an adverse event in 5,625 FDA reports for DOCETAXEL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAIR DISORDER accounts for approximately 3.7% of all adverse event reports for DOCETAXEL, making it a notable side effect.
If you experience hair disorder while taking DOCETAXEL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.